Spot Acne Treatment Oil Free 0.75oz

Description

Spot Acne Treatment is an oil-free formulation available in a 0.75 oz dosage form. This product is designed specifically for the treatment of acne, providing targeted action to help reduce the appearance of blemishes. The formulation is non-comedogenic, ensuring it does not clog pores, making it suitable for various skin types.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The affected area should be covered with a thin layer of the product one to three times daily, depending on the patient's needs and the physician's direction.

Initial treatment should begin with one application per day. Based on the patient's response and under medical guidance, the frequency may be gradually increased to two or three times daily. In cases where dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day.

For patients who will be exposed to sunlight, it is recommended to apply sunscreen after using this product to protect the skin.

Contraindications

Use is contraindicated in patients with very sensitive skin due to the potential for adverse reactions.

Warnings and Precautions

When using this product, healthcare professionals should be aware that the likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently. It is advised to limit the use to one topical acne medication at a time to minimize the risk of irritation.

Patients with very sensitive skin should avoid using this product, as it may exacerbate skin sensitivity and lead to adverse reactions.

In the event that irritation worsens, patients are instructed to discontinue use immediately and consult a healthcare provider for further evaluation and management.

Additionally, if the product is ingested, it is critical to seek emergency medical assistance or contact a Poison Control Center without delay to ensure appropriate care is provided.

Side Effects

Patients using this medication may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. The likelihood of these adverse reactions increases with the simultaneous application of multiple topical agents.

In the event that irritation becomes severe, patients are advised to discontinue use and consult a healthcare professional for further guidance. It is important for patients to monitor their skin condition closely and to adhere to the recommendation of using only one topical acne medication at a time to minimize the risk of irritation.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use to one topical acne medication at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of Spot Acne Treatment Oil Free 0.75oz (salicylic acid cream). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Based on the patient's response, the frequency may be gradually increased to two or three times daily, as needed or directed by a healthcare professional. Should any dryness or peeling of the skin occur, the application frequency should be reduced to once a day or every other day to mitigate these effects.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The use of this medication during pregnancy has not been specifically addressed in the available prescribing information. There are no documented safety concerns related to pregnancy, and no dosage modifications for pregnant individuals are recommended. Additionally, the prescribing information does not outline any special precautions for the use of this medication in pregnant patients. Healthcare professionals should consider the absence of specific data when prescribing this medication to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the context of overdosage, it is important to note that no specific information regarding overdosage has been provided in the available documentation. Healthcare professionals are advised to exercise caution and consider the potential implications of an overdose based on the pharmacological profile of the medication in question.

In the absence of detailed overdosage data, it is recommended that healthcare providers monitor patients closely for any unusual symptoms or adverse effects that may arise. Should an overdose be suspected, standard emergency protocols should be initiated, including supportive care and symptomatic treatment as necessary.

Healthcare professionals are encouraged to consult relevant clinical guidelines and toxicology resources for further management strategies in cases of suspected overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should not use the product if they have very sensitive skin.

Healthcare providers should counsel patients to discontinue use and consult a doctor if they experience severe irritation. While using the product, patients should be instructed to avoid unnecessary sun exposure and to apply sunscreen to protect their skin. Additionally, they should be cautioned to avoid contact with the eyes, lips, and mouth, as well as with hair and dyed fabrics, as the product may cause bleaching.

Patients should be made aware that skin irritation may occur, which can manifest as redness, burning, itching, peeling, or possibly swelling. They should be informed that reducing the frequency of use or opting for a lower concentration of the product may help alleviate irritation.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F). Care should be taken to ensure that the product is kept within this temperature range to maintain its integrity and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to avoid unnecessary sun exposure and to use sunscreen during treatment. Patients are advised to prevent contact with the eyes, lips, and mouth, as well as to avoid contact with hair and dyed fabrics, which may be bleached by the product. In the event of irritation or sensitivity, patients should discontinue use of both the product and any other products being used concurrently, and consult a doctor.

Drug Information (PDF)

This file contains official product information for Spot Acne Treatment Oil Free 0.75oz, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)